By Ann K. Blanc and Katharine J. McCarthy Accurate estimates of the coverage of life saving maternal interventions, such as those that prevent, detect, and treat eclampsia, is one of the major challenges facing the maternal health field. Measuring coverage of…
November 30, 2016
November 30, 2016
November 30, 2016
November 30, 2016
November 30, 2016
November 30, 2016
November 30, 2016
November 30, 2016
November 30, 2016
November 30, 2016
ISSHP 2016 presentations and posters
At ISSHP 2016, Ending Eclampsia researchers shared their findings on PE/E-related quality of care, community perceptions of PE/E-related symptoms, challenges in providing quality health services, and more! See the materials below for more information. Oral presentations: Gloria Adoyi, Project Coordinator “A…
For pre-eclamptic women, access to essential medicines can save lives
By Amy Dempsey and Saumya RamaRao The global health community knows how to prevent women from dying during pregnancy, delivery, and postpartum. The science that describes what works and what does not is out there, and as dissemination channels increase…
Community voices for fewer maternal deaths
By Charlotte Warren The Lancet Maternal Health Series, published last month, calls for stronger appreciation of the voices and needs of women and their families, and emphasizes better incorporation of health providers’ views when defining maternal health priorities. Lynn Freedman’s…
Ending Eclampsia hosts inaugural webinar!
“How Undernutrition and Hypertension Impact Pre-eclampsia/Eclampsia and Pre-term Birth” September 15 at 9 a.m. (EST) Watch recorded presentations here! Presenters: Laura Magee, MD, St. George’s Hospital “The hypertensive disorders of pregnancy (HDPs) – best practices” Tabassum Firoz, MD, The Warren…
Driving Transformative Innovation to Better Detect and Treat Pre-eclampsia/Eclampsia
Pre-eclampsia and eclampsia are among the leading causes of maternal death and disability worldwide. The risk of a pregnant woman dying from it in a developing country is approximately 300 times greater than in developed countries. The World Health Organization…
The Current State of Pre-eclampsia/Eclampsia Prevention and Treatment
The most recent Maternal Health Task Force quarterly newsletter highlighted postpartum hemorrhage and pre-eclampsia/eclampsia – the two leading causes of maternal deaths globally – and focused on magnesium sulphate for treatment of eclamptic convulsions. In response, Sharif Mohammed Ismail Hossain,…
Thank you for joining us at Women Deliver 2016!
On May 16, 2016, Ending Eclampsia in partnership with Every Preemie – SCALE, hosted the PTB/LBW Global Technical Working Group on Implementation Challenges and Solutions. The meeting focused on ending preventable pre-term births and low birth weight babies due to…
Pre-eclampsia/Eclampsia Impacts Mothers and Babies
Each year, 15 million babies are born too soon. Of these, more than one million die from complications related to preterm birth (PTB) – or birth before 37 weeks gestation. Globally, prematurity is the leading cause of perinatal death from…
Ending Eclampsia goes to Women Deliver 2016
And we look forward to seeing you there! Ending Eclampsia, in partnership with Every Preemie – SCALE, is hosting the PTB/LBW Global Technical Working Group on Implementation Challenges and Solutions side event. It will focus on ending preventable pre-term births and low…